Kurt Graves

This profile gathers the share dealings of Kurt Graves across 2 companies, led by Radius Health, Inc. and Achillion Pharmaceuticals Inc. In total, 5 filings cover trades dated from 13 February 2019 to 20 February 2020.

The open-market record consists of 1 sale worth €95k, with no purchase. Outside the open market, there are 2 share grants and 1 option exercise.

The latest filing, published on 24 February 2020, reports a share grant in Radius Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.